Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
19 April, 2024 19:38 IST
Sensex jumps on US Fed policy; Hero, Sun Pharma, L&T rally
Source: IRIS | 18 Sep, 2014, 10.51AM
Rating: NAN / 5 stars.
Comments  |  Post Comment

Indian equities rallied on Thursday on strong overseas inflows after the US Federal Reserve maintained zero interest rates stance. At 10.33 a.m., the Sensex was trading up 240.71 points or 0.90% at 26,872.00 with 26 components gaining. Meanwhile, the Nifty was trading higher by 61.40 points or 0.77% at 8,036.90 with 47 components gaining.

Realty stocks gained the most with a rise of 2.22% followed by Capital Goods (1.68%) and Healthcare (1.61%). Hero Motocorp, Sun Pharma, L&T and Hindalco were major gainers in the Sensex pack. On the other hand, Infosys, HUL and M&M were top losers in the benchmark index.

The BSE Mid and small caps outperformed their larger counterparts gaining 1.40% and 2.07% respectively. Overall market breadth was positive with 1,771 advances against 550 declines.

Shares of Larsen & Toubro (L&T) and Sun Phrama are active in the day's trade. L&T registered a rise in share prices by 1.34% after the company's  subsidiary L&T Oman LLC has won an order from the ministry of defense, Sultanate of Oman against stiff international competition for the construction of Adam Air base.

Sun Pharmaceutical Industries registered a sharp rise in share prices of nearly 2% today after the company and Merck & Co through their respective subsidiaries, announced an exclusive worldwide licensing agreement for Merck's investigational therapeutic antibody candidate, Tildrakizumab (MK-3222). Sun has made upfront payment of USD 80 million.

 Post Comment
Name Email
Comment
Security Code type    into this box
Related Articles
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer